Bio Essence Corp
BIOE· OTC
Filed Aug 15, 2022 · 10-Q · 46 days after period end · 0001213900-22-047894
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $288.14K | $235.93K | $205.09K |
| Net Income | -$164.19K | -$163.54K | -$184.45K |
| EPS Diluted | $0.00 | $0.00 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end